1/ 🚨Recent #PhD publication🚨 Knowledge and Attitudes about Solid Organ #Transplantation for People with HIV in Australia: A Cross-sectional Survey of People with and without #HIV #SOT #TxID #IDSky #TxIDSky #healthequity journals.lww.com/jaids/abstra...

Our recent correspondence in #lancet: “We must improve awareness among people with #HIV and health-care providers of their eligibility to receive and donate organs…we must ensure that equity is a non-negotiable standard.” www.thelancet.com/journals/lan...

A call for equity in organ transplantation for people with HIV

The Lancet Series on solid organ transplantation is a timely call to advance global equity and highlights the importance of ensuring those who might benefit from solid organ transplantation have fair ...

thelancet.com

🚨New Publication🚨 Great to see this #PhD publication out. Knowledge and attitudes about #SOT for people with #HIV among Australian healthcare providers: a cross‐sectional survey onlinelibrary.wiley.com/doi/10.1111/... Thanks to the participants and collaborators for #IDSky #HIVsky #TxIDSky

Knowledge and attitudes about solid organ transplantation for people with human immunodeficiency virus among Australian healthcare providers: a cross‐sectional survey

Background People with human immunodeficiency virus (HIV) (PWH) are experiencing a normalisation in life expectancy, but with an increasing burden of chronic comorbidities and end-stage organ diseas.....

onlinelibrary.wiley.com

Pleased to share results of our discrete choice experiment of the influence of HIV on organ procurement and allocation in Australia #HIVAIDS2025 #healthequity #IDsky #HIVsky #TxIDsky #PhD

🚨Review just out in @hivmedicine.bsky.social 🚨 “Solid organ transplantation in people with #HIV: Outcomes, obstacles and opportunities” #IDSky #HIVSky #TxIDSky ft. David Ruschena, Prof. James McMahon, Prof. Jenny Hoy doi.org/10.1111/hiv....

Solid organ transplantation in people with HIV: Outcomes, obstacles and opportunities

Objective People with HIV experience disparate access to solid organ transplantation (SOT), despite mounting evidence for comparable outcomes. This review aims to understand the outcomes following S...

doi.org

Important #latebreaker study at #CROI2025 SCORPIO-PEP phase III RCT showed ensitrelvir (Day 1: 375mg, Day 2-5: 125mg) reduced PCR positive, symptomatic #COVID19 in HHC if started w/in 72 hrs of index case symptomatic C19 by 67%. Including in those with high risk progression. Need ICH and RACF data!

#CROI2025 Published today: #Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study www.thelancet.com/journals/lan... Great to see truly “long acting” therapies for HIV and PrEP emerging. the bar for #HIV #vaccines is ever higher!

Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study

Following administration of once-yearly intramuscular lenacapavir, median plasma concentrations exceeded those associated with efficacy in phase 3 studies of twice-yearly subcutaneous lenacapavir for ...

thelancet.com

Calling Our Patients “High Risk” Hurts Them "Being called risky or associated w risk b/c of your sexual health decisions makes most people feel ashamed. And that shame is nothing more than another barrier to care. " A banger op-ed by @jncherabiemd.bsky.social www.thebodypro.com/hiv/calling-...

Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination. ja.ma/4i9ghPC

Ten Americas: a systematic analysis of life expectancy disparities in the USA - @thelancet.bsky.social Somber update on the 8 Americas study; highlights growing inequities in life expectancy, impact of structural racism and disproportionate impact of #COVID19 www.thelancet.com/journals/lan...

Dr Eloise Williams gave an important update confirmatory testing for #HIV in Australia. #MicroSky #HIVsky #IDsky #HIVinFocus - Use of accredited NAAT in diagnostics (cf monitoring) on separate sample to initial serology - p24 Ag immunoassay (no longer available) - (traditional) western blot

Vikas Parwani from HIV/AIDS Legal Center shares a brief insight into immigration to Aus for #PWH. Immigration exempt from discrimination laws that protect #PWH. #HIV can be barrier due to perceived cost, but opportunities for ‘health waiver’ exist. HIV not the only barrier #PWH face. #HIVinFocus

A/Prof. Mina John from Royal Perth Hospital, presents Western Australian data on implementation LAI ART in hard to reach populations, mirroring #UCSF data; improved retention in care and virological suppression. Multiple other benefits. #HIVsky #IDsky

A/Prof Janine Trevillyan from #AustinHealth describes the challenges of applying the #REPRIEVEstudy in Australia; we don’t have pitavastatin and use different risk calculators. #IDsky #HIVsky Atorva- and rosuvastatin reduce surrogates of CVD risk, though choosing ideal biomarker can be challenging.

Day 2 #HIVinFocus Prof. Currier from #UCLA offering insights into CVD risk in #PWH. First, association between clonal hematopoiesis and #CVD risk in #HIV demonstrated in several cohorts.

#HIVsky #IDsky Remember cystatin C as an alternative to creatinine for estimating renal function in people with HIV with elevated creatinine on INSTI and/or cobicistat. - nephrologist, Dr Nichita GAVRILESCU #HIVinFocus

Great talk by Endocrinologist A/Prof. Priya Sumithran at #HIVinFocus symposium. - weight loss is an uphill battle - pharmacological management available with additional health benefits - questions remain about functional impact of muscle loss - meds only work while taking them! #IDsky #HIVsky

Prof. Jenny Hoy, summarises ART and weight gain at #HIVinFocus symposium at Alfred Health. #HIVSky

Lower-cost versions of the #HIV prevention drug lenacapavir to be made available in 120 low- & middle-income countries. #IDSky #GlobalHealth #PublicHealth #PrEP www.theguardian.com/global-devel...

‘Gamechanger’ HIV prevention drug to be made available cheaply in 120 countries

Gilead Sciences announces deal to manufacture generic versions of lenacapavir, but critics say it excludes many countries where incidence is highest

theguardian.com

One can try to slice the data however they will, but the ⬇️ in morbidity, mortality and incidence of several infectious diseases due to #vaccination is irrefutable. We’ve seen time and again, the consequences of disruption of immunisation programs (e.g. MMR in Samoa), and ⬇️ in herd immunity #IDsky

Allen Yung's Golden Rules of ID. Copied over from the Other Place for @kottonnelson.bsky.social #IDSky

Great point! We often advocate for a unifying diagnosis (Occam’s razor), but in people with immunocompromise, it’s important not to disregard Hickam’s dictum; “Patients can have as many diseases as they damn well please!” #Medsky #IDSky #TxIDSky

Sonia Koning@sonkoning.bsky.social · 2y ago

Lessons from practice for immunocompromised hosts by Dr Ai Li Yeo and A/Prof Claire Dendle #ForbesWeek #IDSky 1. There can be more than two pathologies in immunocompromised patients

Interesting take in @nytimes.com Most of us know that the individual and #publichealth benefits of #vaccines are irrefutable, but we must take the opportunity to communicate differently about vaccines; listen, learn, and leverage #RFKs skepticism for good. www.nytimes.com/2024/11/15/o...

Opinion | Can America’s Health Survive Robert F. Kennedy Jr.?

What Kennedy gets right.

nytimes.com

Super pleased to receive an award for our research on barriers to #SOT for people with #HIV among clinicians and consumers in Australia. #IDSky #HIVSky #HealthEquity

Y’all are going to need some infectious diseases experts #IDSky Starter Packs IDSky 1 go.bsky.app/LnAQjdq IDSky 2 go.bsky.app/JNfSvQT IDSky 3 go.bsky.app/FeogT7o IDSky 4 go.bsky.app/D1zxj4E IDSky 5 go.bsky.app/NgGSPeF IDSky 6 go.bsky.app/22VBL8z #MedSky

a man in a lab coat says no reason in front of a wall of cards

Alt: a man in a lab coat says “no reason”

media.tenor.com

Impressed by the number of #IDsky community members, already here. Hi!